Literature DB >> 10874495

Immunotherapy of human viral and malignant diseases with genetically modified T-cell clones.

S R Riddell1, E H Warren, M A Gavin, Y Akatsuka, D Lewinsohn, H Mutimer, L Cooper, M S Topp, C Bonini, P D Greenberg.   

Abstract

Entities:  

Mesh：

Year:  2000        PMID： 10874495

Source DB:  PubMed          Journal:  Cancer J        ISSN： 1528-9117            Impact factor:   3.360


× No keyword cloud information.
  3 in total

1.  Transduction of an IL-2 gene into human melanoma-reactive lymphocytes results in their continued growth in the absence of exogenous IL-2 and maintenance of specific antitumor activity.

Authors:  K Liu; S A Rosenberg
Journal:  J Immunol       Date:  2001-12-01       Impact factor: 5.422

Review 2.  Regulation of cancer germline antigen gene expression: implications for cancer immunotherapy.

Authors:  Stacey N Akers; Kunle Odunsi; Adam R Karpf
Journal:  Future Oncol       Date:  2010-05       Impact factor: 3.404

3.  Cloning and large-scale expansion of epitope-specific equine cytotoxic T lymphocytes using an anti-equine CD3 monoclonal antibody and human recombinant IL-2.

Authors:  Robert H Mealey; Matt H Littke; Steven R Leib; William C Davis; Travis C McGuire
Journal:  Vet Immunol Immunopathol       Date:  2007-04-08       Impact factor: 2.046
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.